Variant report
Variant | esv17513 |
---|---|
Chromosome Location | chr6:48745206-48753735 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561976410 | chr6:48745231-48745232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573884704 | chr6:48745234-48745235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115200342 | chr6:48745266-48745267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150575794 | chr6:48745272-48745273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532932087 | chr6:48745277-48745278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551070103 | chr6:48745289-48745290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113346261 | chr6:48745292-48745293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116726434 | chr6:48745314-48745315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2997368 | chr6:48745324-48745325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568618794 | chr6:48745339-48745340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73486461 | chr6:48745345-48745346 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs144183018 | chr6:48745347-48745348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565952332 | chr6:48745364-48745365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146071311 | chr6:48745366-48745367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558301434 | chr6:48745387-48745388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs117327153 | chr6:48745397-48745398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566838786 | chr6:48745400-48745401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535611422 | chr6:48745402-48745403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140066105 | chr6:48745471-48745472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116103111 | chr6:48745482-48745483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149811489 | chr6:48745496-48745497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541007244 | chr6:48745503-48745504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115133449 | chr6:48745505-48745506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577568560 | chr6:48745587-48745588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544569804 | chr6:48745631-48745632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114305266 | chr6:48745644-48745645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544352607 | chr6:48745665-48745666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530549634 | chr6:48745666-48745667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558040078 | chr6:48745694-48745695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs79993572 | chr6:48745708-48745709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562187719 | chr6:48745720-48745721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529451615 | chr6:48745721-48745722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7739538 | chr6:48745767-48745768 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs566332510 | chr6:48745785-48745786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558625951 | chr6:48745798-48745799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34539739 | chr6:48745892-48745893 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570327190 | chr6:48745906-48745907 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533377364 | chr6:48745910-48745911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34953414 | chr6:48745921-48745922 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577883183 | chr6:48745933-48745934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs115485361 | chr6:48746008-48746009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570042081 | chr6:48746042-48746043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537588625 | chr6:48746054-48746055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142924938 | chr6:48746121-48746122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567358141 | chr6:48746135-48746136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534768189 | chr6:48746155-48746156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553009052 | chr6:48746182-48746183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs151109059 | chr6:48746195-48746196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544882400 | chr6:48746199-48746200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374261775 | chr6:48746228-48746229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 16608533 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:48742800-48746200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr6:48742800-48746200 | Enhancers | NHEK | skin |
3 | chr6:48744000-48745800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr6:48744400-48746000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr6:48744800-48746200 | Enhancers | HMEC | breast |
6 | chr6:48745000-48745800 | Enhancers | Esophagus | oesophagus |
7 | chr6:48745800-48746800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr6:48746000-48752600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr6:48746200-48746600 | Weak transcription | HMEC | breast |
10 | chr6:48746600-48747000 | Enhancers | HMEC | breast |
11 | chr6:48747000-48747200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr6:48750000-48750200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr6:48750200-48751400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |